392 related articles for article (PubMed ID: 28032858)
1. Functional roles of sialylation in breast cancer progression through miR-26a/26b targeting ST8SIA4.
Ma X; Dong W; Su Z; Zhao L; Miao Y; Li N; Zhou H; Jia L
Cell Death Dis; 2016 Dec; 7(12):e2561. PubMed ID: 28032858
[TBL] [Abstract][Full Text] [Related]
2. Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer.
Li Y; Sun Z; Liu B; Shan Y; Zhao L; Jia L
Cell Death Dis; 2017 Jun; 8(6):e2892. PubMed ID: 28640257
[TBL] [Abstract][Full Text] [Related]
3. lncRNA MALAT1/miR‑26a/26b/ST8SIA4 axis mediates cell invasion and migration in breast cancer cell lines.
Wang N; Cao S; Wang X; Zhang L; Yuan H; Ma X
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34278507
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs.
Cheng L; Gao S; Song X; Dong W; Zhou H; Zhao L; Jia L
Oncotarget; 2016 Sep; 7(38):61199-61214. PubMed ID: 27533464
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.
Zhao L; Li Y; Song X; Zhou H; Li N; Miao Y; Jia L
Oncotarget; 2016 Sep; 7(37):60074-60086. PubMed ID: 27527856
[TBL] [Abstract][Full Text] [Related]
6. MiR-26a and miR-26b mediate osteoarthritis progression by targeting FUT4 via NF-κB signaling pathway.
Hu J; Wang Z; Pan Y; Ma J; Miao X; Qi X; Zhou H; Jia L
Int J Biochem Cell Biol; 2018 Jan; 94():79-88. PubMed ID: 29208566
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer.
Zhao XX; Yuan QZ; Mu DP; Sun DW; Bo QA; Pan GZ; Li GQ; Cui T; Ding PP; You FP; Hao L; Wang MX; Zhang J
Int J Clin Exp Pathol; 2015; 8(1):368-73. PubMed ID: 25755724
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma.
Kurozumi A; Kato M; Goto Y; Matsushita R; Nishikawa R; Okato A; Fukumoto I; Ichikawa T; Seki N
Int J Oncol; 2016 May; 48(5):1837-46. PubMed ID: 26983694
[TBL] [Abstract][Full Text] [Related]
9. Loss of post-transcriptional regulation of DNMT3b by microRNAs: a possible molecular mechanism for the hypermethylation defect observed in a subset of breast cancer cell lines.
Sandhu R; Rivenbark AG; Coleman WB
Int J Oncol; 2012 Aug; 41(2):721-32. PubMed ID: 22664488
[TBL] [Abstract][Full Text] [Related]
10. Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2.
Tan S; Ding K; Li R; Zhang W; Li G; Kong X; Qian P; Lobie PE; Zhu T
Breast Cancer Res; 2014 Apr; 16(2):R40. PubMed ID: 24735615
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-26b inhibits tumor metastasis by targeting the KPNA2/c-jun pathway in human gastric cancer.
Tsai MM; Huang HW; Wang CS; Lee KF; Tsai CY; Lu PH; Chi HC; Lin YH; Kuo LM; Lin KH
Oncotarget; 2016 Jun; 7(26):39511-39526. PubMed ID: 27078844
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of the α2,3-sialic acid residues in breast cancer is associated with metastatic potential.
Cui H; Lin Y; Yue L; Zhao X; Liu J
Oncol Rep; 2011 May; 25(5):1365-71. PubMed ID: 21344161
[TBL] [Abstract][Full Text] [Related]
13. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.
Li N; Miao Y; Shan Y; Liu B; Li Y; Zhao L; Jia L
Cell Death Dis; 2017 May; 8(5):e2796. PubMed ID: 28518139
[TBL] [Abstract][Full Text] [Related]
14. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer.
Kato M; Goto Y; Matsushita R; Kurozumi A; Fukumoto I; Nishikawa R; Sakamoto S; Enokida H; Nakagawa M; Ichikawa T; Seki N
Int J Oncol; 2015 Aug; 47(2):710-8. PubMed ID: 26063484
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA HOTAIR promotes renal cell carcinoma malignancy through alpha-2, 8-sialyltransferase 4 by sponging microRNA-124.
Pan Y; Wu Y; Hu J; Shan Y; Ma J; Ma H; Qi X; Jia L
Cell Prolif; 2018 Dec; 51(6):e12507. PubMed ID: 30105850
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways.
Fukumoto I; Hanazawa T; Kinoshita T; Kikkawa N; Koshizuka K; Goto Y; Nishikawa R; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
Br J Cancer; 2015 Mar; 112(5):891-900. PubMed ID: 25668004
[TBL] [Abstract][Full Text] [Related]
20. miR-146a and miR-146b promote proliferation, migration and invasion of follicular thyroid carcinoma via inhibition of ST8SIA4.
Ma W; Zhao X; Liang L; Wang G; Li Y; Miao X; Zhao Y
Oncotarget; 2017 Apr; 8(17):28028-28041. PubMed ID: 28427206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
